Explorer
Know how is ZyCoV-D vaccine different from other
The phase II study of the vaccine ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive phase I/II dose escalation, multi-centric, randomised, double-blind placebo controlled study. The vaccine was found to be safe and immunogenic. Watch video to know more.
India
Big Update: Confusion Over Champat Rai’s Arrival as High-Stakes Session Set to Begin
Latest Update: Ram Temple Trust Meeting Delayed as Members Arrive; Champat Rai Reaches Venue, Anil Mishra Yet to Arrive
Breaking news: Champat Rai, Anil Mishra Skip Crucial Session on Their Resignations
BREAKING: Ram Temple Trust Convenes as Resignations of Two Senior Members Dominate Agenda Today
BREAKING: Ram Temple Trust Meeting Sees Key Absences as Senior Trustees Arrive Amid Questions
View More
Top Headlines
India
Nirav Modi Extradition Soon? Final Legal Hurdle Cleared After ECHR Rejection: Reports
World
Bloodshed Inside Sri Lanka Jail: 25 Killed, Over 100 Injured In Violent Clash
World
Iran Mourns Khamenei: Millions Join Massive Funeral Procession In Tehran
Cities
Maharashtra Rains: CM Fadnavis Reviews Situation, Warns Next 48 Hours Critical
Trending News
